The binding energy of the most active compounds in comparison to the co-crystallized ligand for each prospective target.
| No. | Compound | EGFR | HER-2 | TOP-II | Aromatase |
|---|---|---|---|---|---|
| 1 | 13c | −8.0 | −10.4 | −10.7 | −9.9 |
| 2 | 11e | −7.9 | −8.9 | −9.5 | −9.1 |
| 3 | 7c | −7.7 | −10.3 | −10.2 | −10.6 |
| 4 | Co-crystallized ligand in EGFR | −8.1 | — | — | — |
| 5 | Co-crystallized ligand in HER-2 | — | −11.6 | — | — |
| 6 | Co-crystallized ligand in Top-II | — | — | −10.9 | — |
| 7 | Co-crystallized ligand in aromatase | — | — | — | −10.7 |